The Diagnostic Value Of Suppressor Of Cytokine Signaling-1 (Socs-1) Methylation For Human Hepatocellular Carcinoma (Hcc): A Meta-Analysis Based On Data From 15 Studies

C Ye,D Zhu,J Lu,X Zhang,L Li

2016-01-01

Abstract:AIM: To assess the potential diagnostic value of suppressor of cytokine signaling-1 (SOCS-1) methylation in human hepatocellular carcinoma (HCC). Methods: Search results were filtered with inclusion criteria. Relative study data was collected. Quality of included studies was assessed by QUADAS2; sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were calculated with 95% CI. A summary receiver operating characteristic (SROC) curve was used to assess the diagnostic power. Meta-regression was applied to analyze observed heterogeneity, and publication bias was evaluated with Deeks' test. Results: 807 HCC and 664 non-tumor samples were included. The sensitivity, specificity, PLR, NLR, and DOR of the SOCS-1 methylation test were 0.619 (0.522-0.708), 0.803 (0.558-0.930), 3.148 (1.278-7.750), 0.474 (0.361-0.622), and 6.639 (2.213-19.917), respectively. The area under the curve (AUC) was 0.71 (0.67-0.75). Four factors of study were included in meta-regression and none of them were significant (P > 0.05). No significant publication bias was detected using Deeks' test (P = 0.194). Conclusion: Our results indicate that SOCS-1 methylation has a potential diagnostic value in HCC. SOCS-1 methylation together with a-fetoprotein (AFP) may increase diagnostic sensitivity and specificity; however, further investigation is needed.